Using next-generation gene technology to help children with blood cancers in low-income countries
Defining the molecular landscape of paediatric and adolescent acute leukaemia in Tanzania
Defining the molecular landscape of paediatric and adolescent acute leukaemia in Tanzania
This year, for Childhood Cancer Awareness Month (CCAM), CCLG has been working hard to raise awareness of the long-term impact of childhood cancer and its treatments.
Sarah Davis' daughter Emma was diagnosed with acute lymphoblastic leukaemia (ALL) as a 12-year-old. She writes about the support the family received and the progress Emma has made since finishing treatment
First formed to establish clinical trials in childhood cancer, research has always been an integral part of CCLG’s work. Ellie Ellicott, CCLG Research Communications Executive, tells us more about its research journey and how the experiences of those that matter the most are helping shape future directions.
We have some big and exciting plans for 2025, and we are looking forward to getting started. But first, let's look all the amazing things that your support has helped achieve this year...
We now lead one of the UK’s largest childhood cancer research networks, thanks to our partner charities and to your fantastic support. Find out what your support has achieved...
Childhood cancer research has increased survival rates from just three in 10 children in the 1960s to over eight in ten children today thanks to dedicated researchers. So, what's next?
Join us to look at what CCLG achieved in 2023 with your support - and how you have been part of changing the future for children with cancer.
On Saturday 4 February, it is World Cancer Day. The theme for this year is ‘Close the care gap’. We take a look at what needs to be done to help children with cancer globally.